Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Comprehensive geriatric sits at the center of this dementia and brain health question.
Comprehensive geriatric assessment after age 75 should include full cognitive testing because cognitive decline is one of the most underdiagnosed conditions in older adults, yet it fundamentally changes how we approach every other aspect of their care. When an 78-year-old arrives at a doctor’s office complaining of increased falls, worsening medication adherence, or difficulty managing finances, the root cause is often undiagnosed cognitive impairment—yet many standard geriatric assessments skip formal testing altogether. Without understanding a person’s actual cognitive status, we make inappropriate medication recommendations, create care plans that won’t work, and miss the critical window for early intervention in dementia and other treatable cognitive conditions. The reason cognitive testing belongs in every comprehensive geriatric assessment for adults over 75 is straightforward: cognitive function is the foundation upon which all other health decisions are built.
A person cannot safely take complex medications without understanding how to take them. They cannot manage chronic disease without remembering their care plan. They cannot communicate their symptoms accurately or provide informed consent for treatments. Cognitive impairment affects how older adults live, what support they need, and what outcomes are actually achievable—yet it’s often invisible until a crisis forces a hospital admission or family intervention.
Table of Contents
- Why Cognitive Assessment Cannot Be Optional in Older Adults Over 75
- Types of Cognitive Testing and What They Actually Reveal
- How Undetected Cognitive Impairment Derails Medical Care and Safety
- Building Cognitive Assessment Into the Geriatric Evaluation Practically
- How Cognitive Testing Prevents Misdiagnosis of Depression and Delirium
- Cognitive Testing Results and Family Communication
- The Future of Cognitive Assessment in Geriatric Care
- Conclusion
Why Cognitive Assessment Cannot Be Optional in Older Adults Over 75
The prevalence of cognitive impairment in adults over 75 is staggering: approximately 1 in 3 people in this age group have some form of cognitive decline, and roughly half of them don’t know it. Many older adults and their families normalize memory loss as “just getting older,” which allows dementia and other conditions to progress undetected for years. The problem is compounded because cognitive decline often masks itself—a person with mild cognitive impairment might actually perform well in a single office visit, appearing sharp and coherent during routine appointments while struggling significantly with complex decision-making at home. What makes cognitive assessment especially critical at age 75 is that this is precisely the age when several conditions either appear for the first time or accelerate in progression.
Alzheimer’s disease, vascular dementia, Lewy body dementia, and frontotemporal dementia all have different presentations, different trajectories, and different treatment implications. Without formal testing, a clinician cannot distinguish between normal aging, mild cognitive impairment, dementia, depression masquerading as cognitive decline, delirium from an infection, or medication-induced cognitive problems. Consider a 76-year-old woman whose daughter notices she’s “seemed forgetful” over the past year. Her primary care doctor might attribute this to stress or normal aging. But formal cognitive testing reveals mild cognitive impairment with a pattern suggesting early Alzheimer’s disease—which opens the door to disease-modifying treatments, family education about progression, and planning that wouldn’t have happened otherwise.
Types of Cognitive Testing and What They Actually Reveal
Comprehensive cognitive assessment goes far beyond the brief Mini-Cog or Montreal Cognitive Assessment many clinicians use in standard office visits. While these brief screens are useful for case-finding, they lack the granularity to diagnose specific conditions or guide clinical decisions. A full neuropsychological evaluation—which typically takes 2-4 hours and evaluates memory, executive function, language, visuospatial abilities, attention, and processing speed—can reveal the distinctive cognitive signature of different dementia types and identify reversible causes like vitamin B12 deficiency or thyroid dysfunction. The critical limitation, however, is that comprehensive neuropsychological testing isn’t available or affordable everywhere, and it’s often not covered by insurance without prior authorization.
Many older adults live in rural areas where neuropsychologists aren’t available. Others face prohibitive out-of-pocket costs. This reality creates a two-tiered system: wealthy older adults in urban centers get thorough cognitive evaluation, while others don’t. Additionally, some people have legitimate concerns about the burden of testing—sitting for hours of cognitive tasks can be exhausting, especially for someone who is already struggling with fatigue or anxiety around their cognitive changes. A middle ground approach involves using validated screening tools like the Montreal Cognitive Assessment or the MOCA, combined with collateral information from family members and careful attention to functional changes in activities of daily living, to identify who needs fuller evaluation.
How Undetected Cognitive Impairment Derails Medical Care and Safety
When a 79-year-old with undiagnosed mild cognitive impairment is prescribed a new blood pressure medication with complicated dosing instructions, what often happens isn’t adherence—it’s missed doses, doubled doses from confusion, or the medication sitting in a bottle while blood pressure control deteriorates. The clinician sees “non-adherence” and might add additional medications or refer to a behavioral health specialist, when the real problem is cognitive. Similarly, people with early dementia are more vulnerable to medication interactions because they don’t remember which medications they’re already taking, they can’t track their symptoms accurately to report to doctors, and they may not recognize or report side effects.
Beyond medications, cognitive impairment affects whether older adults can safely live independently, manage finances, and recognize danger. The consequences aren’t theoretical—studies consistently show that older adults with undetected cognitive impairment have higher rates of falls, higher rates of hospitalizations from preventable conditions like dehydration and infection, and worse surgical outcomes because they can’t follow post-operative instructions. An 81-year-old man scheduled for knee replacement surgery appears cognitively intact in the surgeon’s office but actually has moderate cognitive impairment; he struggles to follow the complex pre-operative instructions, forgets the physical therapy regimen, and ends up with a worse surgical outcome than he otherwise would have had. The same person might be vulnerable to financial exploitation by scams or unscrupulous people who recognize his cognitive vulnerabilities even if his family doesn’t.
Building Cognitive Assessment Into the Geriatric Evaluation Practically
The practical reality is that comprehensive cognitive assessment should happen at multiple levels, with the depth depending on context and availability. At minimum, every older adult over 75 should have a brief cognitive screen as part of their annual comprehensive geriatric assessment—this takes 5-10 minutes and can identify people who need fuller evaluation. Validated tools like the Montreal Cognitive Assessment (MOCA), Mini-Cog, or Clock Drawing Test serve this purpose well. For anyone who screens positive, or for anyone with functional decline that can’t be explained by physical health alone, more comprehensive evaluation is appropriate.
Where resources allow, this fuller evaluation might involve a detailed neuropsychological workup by a specialist. Where resources are limited, a combination of careful history-taking from the patient and an informant (usually a family member), functional assessment, and office-based cognitive testing can provide much of the same information. The tradeoff is that in-office assessment is less standardized and may miss subtle deficits that specialized testing would catch—but in-office assessment is accessible, affordable, and better than no cognitive evaluation at all. Some healthcare systems are now training primary care clinicians to do more thorough cognitive assessment themselves, which improves accessibility but requires significant clinician time and training that isn’t always available.
How Cognitive Testing Prevents Misdiagnosis of Depression and Delirium
One of the most common pitfalls in geriatric care is confusing depression with cognitive impairment—or worse, assuming someone has cognitive impairment when they actually have depression. A 77-year-old who has lost interest in activities, feels hopeless, and performs poorly on cognitive testing might have dementia—or might have major depressive disorder, which causes genuine cognitive slowing and memory problems that look like dementia on cursory examination. Formal cognitive assessment can distinguish between depression-related cognitive slowing (which improves with treatment of the depression) and primary cognitive pathology (which doesn’t). The warning here is that assuming someone has dementia when they actually have depression can lead to tragic outcomes: depression is highly treatable in older adults, but if it’s misattributed to irreversible dementia, the opportunity for treatment is lost.
Similarly, delirium from infection, medication toxicity, or metabolic imbalance can masquerade as new-onset dementia. An 80-year-old woman’s family notices acute onset of confusion; without cognitive baseline testing, the clinician might diagnose dementia. But formal assessment reveals that she likely has delirium—acutely altered mental status that requires investigation of its underlying cause. With the baseline knowledge from prior cognitive testing, this distinction becomes much clearer. The limitation here is that cognitive testing takes time and resources that emergency departments and acute care settings often don’t have, so in crisis situations, the baseline information from prior comprehensive assessment becomes even more valuable.
Cognitive Testing Results and Family Communication
Delivering cognitive test results to older adults and their families is an underappreciated clinical skill. When testing reveals mild cognitive impairment or dementia, the information must be communicated with clarity about what the diagnosis actually means, what the likely progression might be, and what interventions exist. Many families are terrified of dementia and may refuse to hear the diagnosis or deny its implications. Others want detailed predictions about timeline and severity that no test can accurately provide.
A skilled clinician using cognitive test results can educate families about realistic expectations, identify whether the person is safe to drive or manage medications independently, and discuss advance planning while the person with cognitive impairment can still participate meaningfully in those conversations. An important example: formal cognitive test results that document mild cognitive impairment can support medical leave decisions, disability claims, and guardianship proceedings in ways that clinical impression alone cannot. If an older adult needs legal protection of their assets due to cognitive vulnerability to exploitation, documented cognitive testing strengthens that case considerably. Conversely, cognitive test results that come back normal can reassure a family member worried about normal aging and prevent unnecessary specialist referrals or premature life changes based on unfounded concerns.
The Future of Cognitive Assessment in Geriatric Care
As our population ages, comprehensive geriatric assessment will increasingly need to include cognitive testing as standard practice rather than optional add-on. Emerging biomarkers for Alzheimer’s disease—blood tests that can detect pathological proteins years before cognitive symptoms appear—may soon change how we think about cognitive screening. Rather than waiting until someone has cognitive decline to investigate, we might identify preclinical disease in asymptomatic older adults, which raises new questions about what we do with that information and whether early intervention is beneficial.
The challenge ahead is democratizing access to comprehensive cognitive assessment so that older adults from all backgrounds and geographic locations can benefit from it. This likely means training more primary care clinicians in standardized cognitive assessment, developing accessible telehealth options for neuropsychological evaluation, and advocating for insurance coverage that makes testing affordable rather than prohibitively expensive. The goal is a healthcare system where a 76-year-old in rural Montana receives the same quality of cognitive assessment as someone in an academic medical center—because cognitive function is too important to leave to chance.
Conclusion
Comprehensive geriatric assessment for adults over 75 must include full cognitive testing because cognitive impairment is common, often undiagnosed, and profoundly affects every other aspect of health, safety, and independence. Without understanding someone’s actual cognitive status, we make medical decisions that won’t work, miss treatable conditions, prescribe medications that won’t be taken safely, and fail to implement the support systems people actually need. Cognitive testing isn’t a luxury add-on—it’s foundational information that should inform every other clinical decision.
If you’re over 75 or have a loved one in this age group, asking about cognitive assessment should be a routine part of healthcare conversations. If your clinician hasn’t formally assessed cognition, ask why, and request appropriate screening or evaluation if there’s any concern. Detecting cognitive impairment early, distinguishing between normal aging and pathological decline, and building care plans around realistic cognitive capacity is one of the most valuable things geriatric medicine can offer.
You Might Also Like
- Why Your Annual Physical Should Include a Cognitive Screening After Age 55 According to the AMA
- The Cognitive Assessment Baseline Every Adult Should Get at Age 50 and Why It Matters
- Why Physical Therapy After a Hip Fracture Is Critical for Preventing Cognitive Decline in Seniors
For more, see Alzheimer’s Association — caregiving.
